MedPath

苏州华益美生物科技有限公司

Ownership
-
Established
2011-07-25
Employees
-
Market Cap
-
Website
www.bacme-bio.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

6

NMPA:6

Drug Approvals

Diagnostic Kit for Antibody to Hepatitis C Virus (CLIA)

Product Name
丙型肝炎病毒抗体诊断试剂盒(化学发光免疫法)
Approval Number
国药准字S20230060
Approval Date
Oct 24, 2023
NMPA

Diagnostic Kit for Antigen and Antibody of Human Immunodeficiency Virus(CLIA)

Product Name
人类免疫缺陷病毒抗原抗体诊断试剂盒(化学发光免疫法)
Approval Number
国药准字S20230059
Approval Date
Oct 24, 2023
NMPA

Diagnostic Kit of Hepatitis B Virus surface Antigen(CLIA)

Product Name
乙型肝炎病毒表面抗原诊断试剂盒(化学发光免疫法)
Approval Number
国药准字S20230057
Approval Date
Oct 24, 2023
NMPA

Diagnostic Kit for Antibody to Treponema Palllidum (CLIA)

Product Name
梅毒螺旋体抗体诊断试剂盒(化学发光免疫法)
Approval Number
国药准字S20230058
Approval Date
Oct 24, 2023
NMPA

Hepatitis B Virus Hepatitis C Virus Human Immunodeficiency Virus (1+2) Real-Time PCR Kit

Product Name
乙型肝炎病毒、丙型肝炎病毒、人类免疫缺陷病毒(1+2型)核酸检测试剂盒(PCR-荧光法)
Approval Number
国药准字S20191008
Approval Date
Sep 7, 2023
NMPA

Hepatitis B Virus Hepatitis C Virus Human Immunodeficiency Virus (1+2) Real-Time PCR Kit

Product Name
乙型肝炎病毒、丙型肝炎病毒、人类免疫缺陷病毒(1+2型)核酸检测试剂盒(PCR-荧光法)
Approval Number
国药准字S20130011
Approval Date
Sep 7, 2023
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.